Intersectin protein regulation by microRNAs in HEK cells and human neuronal stem cells by Kõbin, Mihkel
  
 
 
UNIVERSITY OF HELSINKI 
FACULTY OF BIOLOGICAL AND ENVIRONMENTAL SCIENCES 
INSTITUTE OF BIOTECHNOLOGY 
 
 
 
 
 
 
Intersectin protein regulation by microRNAs in HEK cells and 
human neuronal stem cells 
 
Master’s thesis 
30 cr 
 
Mihkel Kõbin 
 
Supervisors: Andrii Domanskyi, Dmytro Gerasymchuk 
 
 
 
 
 
 
 
HELSINKI 2020 
  
 
 
Tiedekunta – Fakultet – Faculty 
Faculty of Biological and Environmental 
Sciences 
Koulutusohjelma – Utbildningsprogram – 
Degree Programme 
Master’s programme in Neuroscience 
Tekijä – Författare – Author 
Mihkel Kõbin 
Työn nimi – Arbetets titel – Title 
Intersectin protein regulation by microRNAs in HEK cells and human neuronal stem cells 
Oppiaine/Opintosuunta – Läroämne/Studieinriktning – Subject/Study track 
Neuroscience 
Työn laji – Arbetets art – Level 
Master’s Thesis 
Aika – Datum – Month 
and year 
August 2020 
Sivumäärä – Sidoantal – 
Number of pages 
51 
Tiivistelmä – Referat – Abstract 
 
  Intersectins (ITSNs) are important scaffold and adaptor proteins that play an important role in 
various cellular processes such as endocytosis. Although we know a lot about their function, there 
is little information on the regulation of these proteins. On the other hand, microRNAs have been 
shown to have an extensive function in regulating numerous genes in animals and their 
dysfunction is credited for down regulation of many proteins. In this study, I demonstrate that 
microRNAs are potential regulators of ITSNs in HEK293 cells and human neuronal cell cultures.  
  In this study, I cloned 3’UTRs of different isoforms of intersectins (ITSNs) and microRNAs to 
the expression vectors to express them in cells. I then transfected HEK293T or neuronal stem cell 
line (HEL47.2) with the constructed vectors and used various methods to analyse the effect of 
microRNAs on the expression of ITSNs. The main methods I used were dual-luciferase assay, 
reverse transcription quantitative PCR and western blotting, human neuronal stem cell culturing 
and lentiviral transduction. 
  My results demonstrate that there were two microRNAs that stood out from other and had a 
significant downregulation of ITSNs mRNA levels in HEK293T cells. Those were miR-124 and 
miR-19. However, in the human neuronal cell line I did not observe a significant alteration of the 
ITSNs transcript level. Additionally, I suggest that the given microRNAs regulate protein levels 
by promoting the decay of the ITSN transcripts. However, more studies are needed to show a 
stronger causative effect of microRNAs on ITSNs. Subsequent studies should also look at how 
multiple microRNAs can influence gene expression cooperatively. 
 
Avainsanat – Nyckelord – Keywords 
Instersectins (ITSNs), microRNAs (miRs), endocytosis, 3’ untranslated regions (3’UTR) 
Ohjaaja tai ohjaajat – Handledare – Supervisor or supervisors 
Docent Andrii Domanskyi, Research fellow Dmytro Gerasymchuk 
  
 
 
Säilytyspaikka – Förvaringsställe – Where deposited 
HELDA - Helsingin yliopiston digitaalinen arkisto / HELDA - Helsingfors universitets digitala 
publikationsarkiv /HELDA - Digital Repository of the University of Helsinki 
Muita tietoja – Övriga uppgifter – Additional information 
  
 
 
 
Table of Content 
 
List of Abbrevations ................................................................................................................... 1 
Introduction ................................................................................................................................ 2 
1. Literature review .................................................................................................................... 3 
1.1. Mechanism of clathrin-mediated endocytosis ................................................................. 3 
1.2. Endocytosis in neurons .................................................................................................... 6 
1.3. Intersectins family and their role in clathrin-mediated endocytosis ................................ 8 
1.3.1. Genetics and structure of intersectins ....................................................................... 8 
1.3.2. Function of Intersectins in neuronal clathrin-mediated endocytosis ...................... 10 
1.3.3. Role of intersectins in neurodegenerative diseases ................................................. 12 
1.4. microRNAs: biogenesis, mechanism of action and dysregulation in neurodegenerative 
diseases ................................................................................................................................. 13 
Aims of the study ..................................................................................................................... 14 
2. Materials and Methods ......................................................................................................... 15 
2.1. Culturing of cell lines .................................................................................................... 15 
2.1.1. HEK 293T ............................................................................................................... 15 
2.1.2. Human neuronal stem cells ..................................................................................... 15 
2.2. Design of primers and plasmids .................................................................................... 16 
2.2.1. Design of miRNA oligonucleotides and 3’UTRs cloning primers ......................... 16 
2.2.2. Construction of miRNA expressing plasmids ......................................................... 18 
2.2.3. Construction of plasmids bearing 3’UTRs of ITSN1/2 .......................................... 19 
2.2.4. Construction of lentivirus transfer plasmids for miRNA expression ...................... 21 
2.3. Transformation .............................................................................................................. 22 
2.4. Isolation of plasmid DNA, digestion analysis and sequencing ..................................... 22 
2.5. Transfection of HEK293T ............................................................................................. 23 
  
 
 
2.6. Production of lentiviral particles ................................................................................... 23 
2.7. Transduction of neuronal cells ...................................................................................... 24 
2.8. Dual-luciferase reporter assay ....................................................................................... 25 
2.9. RNA isolation and RT-qPCR ........................................................................................ 26 
2.10. Western blotting .......................................................................................................... 28 
2.11 Statistical analysis ......................................................................................................... 29 
3. Results .................................................................................................................................. 30 
3.1 Selection of microRNAs ................................................................................................. 30 
3.2. Regulation of 3’UTRs of intersectins by microRNAs in HEK293T cells .................... 31 
3.3. Endogenous regulation of ITSNs in HEK293T cells by microRNAs ........................... 34 
3.4. ITSNs regulation in human neuronal stem cells ............................................................ 36 
4. Discussion ............................................................................................................................ 39 
Acknowledgements .................................................................................................................. 42 
References ................................................................................................................................ 43 
 
 
 
  
1 
 
List of Abbrevations 
 
3’UTR – 3’ untranslated region 
AD – Alzheimer’s disease 
Amp – ampicillin 
AP2 – adaptor protein 2 
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Introduction 
 
  For cells and tissues to function properly and carry out their tasks, they need to interact and 
communicate with one another by sending different kinds of signals to each other. In biological 
systems, the main way of communicating with one another is by sending chemical molecules 
from one cell to activate certain responses in other cells. Often, for cells to respond to the 
chemical signal, a given molecular cargo needs to be taken inside the cell (internalized) by a 
widespread and fundamental cellular process in eukaryotes, called endocytosis. In the most 
general form, the molecular cargo that is needed to be taken into the cell first interacts with 
cellular surface proteins. Then, the membrane buds inward and wraps around the cargo until 
the vesicle that is formed around it loses contact with the cell membrane and travels to its 
destination inside the cell. There are many endocytic pathways that vary in the formation, 
protein content and the structure of the vesicle. Currently, endocytosis as a process is divided 
into three major categories: clathrin-mediated endocytosis, caveolae-mediated endocytosis and 
clathrin-independent endocytosis. In each type of endocytosis, after the uptake of the cargo, the 
endosomes are merged into common early endosomes. From there they can be further 
transported back to cell surface, to Golgi complex or across other compartments of the cell 
(Elkin, 2017). In this study, I will focus more on a clathrin-mediated endocytosis. 
  Clathrin-dependant/-mediated endocytosis is known to exist in all described eukaryotic 
organisms and was likely present in the last common ancestor of eukaryotes, more than billion 
years ago (Wideman, Leung, Field, & Dacks, 2014). One of the first reports of endocytic 
pathways is known from 1960s paper from Rosenbluth and Wissing about the uptake of intact 
ferritin proteins by toad spinal ganglion neurons. With a series of electron microscopy images, 
the authors were able to demonstrate that entire ferritin proteins were internalized by neurons. 
At the time, it was very surprising that neurons in general conduct such function. Authors 
described these small bodies as „coated“ vesicles and called the process a pinocytosis (1964). 
Nowadays, it is known as endocytosis and pinocytosis, often described as macropinocytosis, is 
now defined as a cellular uptake of bulk solutes without passing the cell membrane (Doherty & 
McMahon, 2009). 
  Intersectin or ITSN protein is known to be an important mediator in the process of endocytosis. 
It is a short scaffold and adaptor protein and its main role there is to initiate endocytosis by 
recruiting other proteins to the clathrin-mediated endocytic machinery. Lack of this protein or 
overexpression could potentially lead to the significant disruption of endocytosis which in turn 
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could lead to physiological stress. Regulation of gene expression by microRNAs is also known 
to play important part in human physiology. Moreover, many miRs are identified to function in 
brain where they target a variety of proteins such as BDNF, MAPT and LRRK2 (Sharma & Lu, 
2018). The aim of my thesis was to study the regulation of ITSN proteins and its isoforms by 
microRNAs. In this work I used HEK293T and human neuronal cells HEL47.2 to express a 
variety of microRNAs to observe the expression levels of ITSN genes.  
 
1. Literature review 
 
1.1. Mechanism of clathrin-mediated endocytosis 
 
  Though the endocytosis as a process itself is conceptually fairly simple, there are still aspects 
that need deeper look. Over many decades, more than 50 different cytosolic proteins have been 
found to be part of endocytic machinery. Every protein in this process have its own certain 
function so that the whole pathway can run in a highly ordered manner (Kaksonen & Roux, 
2018).  
  Clathrin protein is a central component in a clathrin-dependant endocytosis. The protein is 
made of a heavy chain (about 190 kDa) and a light chain (about 25 kDa). The heavy chain is 
made of three triskelions – outward protruding structures that resemble legs (Fig. 1.1). 
Triskelion structure helps clathrin to work as a structural backbone for clathrin-coated 
endosomes. All three legs of the clathrin interact with other triskelias and ultimately form a 
circular polygonal lattice around the vesicles (Kaksonen & Roux, 2018). 
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Figure 1.1. In image A, a structure of clathrin coated vesicle that is obtained by cryo-electron microscopy is shown. 
Red, yellow and green colours highlight individual clathrin proteins. Clathrin molecule (colored in red) have three 
triskelias that extend out. Both yellow and red clathrins interact with each other by aligning their heavy chains. 
Image B was obtained by electron microscopy and shows multiple lattices of clathrin-coated vesicle on the surface 
of fibroblasts (Kaksonen & Roux, 2018). 
 
  Clathrin-coated endosomes go through many morphological stages from the initiation to the 
uncoating of clathrin lattice. Based on the structural studies, the whole process has been divided 
into five separate stages. The formation of the endosome starts with the nucleation (McMahon 
& Boucrot, 2011). At first, the coating proteins need to assemble to the membrane. The initial 
budding module is formed by the following scaffolding proteins: FCH domain only proteins 
(FCHO), EPS15, epsin protein and lastly intersectin (ITSN) proteins (Kaksonen & Roux, 2018). 
These proteins bind specifically to the phosphoinositides (PIP2) in the lipid bilayer which 
facilitate the assemble of vesicle forming proteins (Kaksonen & Roux, 2018). 
  The next step in this process is a cargo selection. Proteins in an early budding endosome are 
thought to bind adaptor protein 2 (AP2) at this stage. AP2 protein binds to the membrane 
receptors that are bound to certain cargo molecules. AP2 is the second most abundant protein 
in clathrin-mediated endosomes after clathrin. AP2 is a heterotetrameric adaptor protein which 
has multiple isoforms with combinations of different subunits (α, β2, µ2, σ2). AP2 binds to the 
cargo-specific adaptor protein thus mediating selection of molecular cargos. Currently, 
numerous receptor binding accessory proteins present in different cell types are known, which 
bind to different receptors and all of these cargo-specific proteins always bind to core adaptor 
AP2. Thus, it is also thought that the cargo selection could start at the same time as a nucleation 
stage (McMahon & Boucrot, 2011). Studies with AP2 knockout models have observed that 
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these vesicles also lack clathrin proteins. This, in turn, suggest the interaction between AP2 and 
clathrin (Motley, Bright, Seaman, & Robinson, 2003). 
  After recruitment of all the proteins to the site of endocytosis clathrin coat assemble occurs. 
Clathrin molecules polymerize and start to form the lattice-like structure around the vesicle. As 
the polymerization expands, the forming vesicle also invaginates more inward into the cell 
leading to the generation of a mature clathrin-mediated vesicle (McMahon & Boucrot, 2011). 
The bending of the membrane with the subsequent elongation of the invagination requires force 
production to overcome mechanical barriers – membrane tension and turgor pressure. Although 
the exact mechanism is still not known entirely, there are numerous theoretical models and 
chemical pathways through which cells can overcome membrane tension. According to one 
hypothesis, actin network around the site of endocytosis is responsible for generating membrane 
deformation. It is thought to be achieved through fast actin polymerization and 
depolymerization. But overall this question is still far from resolved (Lacy, 2018). 
  The release of the clathrin-coated vesicle or the vesicle scission depends on the GTPase 
dynamin. Dynamin is recruited to the complex by BAR-domain proteins to which it binds. 
Dynamin is a mechanochemical enzyme that uses energy from GTP hydrolysis to remodel 
membrane. Dynamins polymerize into a cylindrical scaffold at the neck of the endosome 
vesicles. From there the hydrolysis of the GTP generates a fission between the membrane and 
vesicle ultimately causing it to detach from the membrane (Bashkirov et al., 2009). Once the 
endosome is detached, clathrin coated lattice will also start to be disassembled back to 
individual clathrin proteins. It is catalysed by ATPase heat shock cognate 70 (HSC70) which is 
recruited by its cofactor auxilin. This allows uncoated vesicle to travel and fuse with its target 
destination – early endosomes. Meanwhile, the disassembled clathrins will be recycled again to 
form new endosomes (McMahon & Boucrot, 2011).  
 
 
  
6 
 
 
Figure 1.2. In the upper panel: The proposed five steps of clathrin-mediated endocytosis starting from nucleation 
(A), followed by cargo selection (B), coat assembly (C), scission (D) and lastly, uncoating (E). In the lower panel, 
images obtained by electron microscopy are shown demonstrating the corresponding steps in vivo. Scale bar: 200 
nm. (McMahon & Boucrot, 2011; Haucke & Kozlov, 2018). 
 
1.2. Endocytosis in neurons 
 
  The basics of the endocytic process is similar in neurons as it is in other cell types. However, 
there are some special properties in order to meet the needs of the neurons, especially, in the 
cargo specificity and the speed of the process in cases of a rapid and repeated firing between 
pre- and postsynaptic neurons (Saheki & Camilli, 2012). Endosomal trafficking has important 
roles in numerous aspects of neuronal processes, particularly in cell survival, axonal growth 
and guidance, dendritic branching and cell migration. Interestingly, in neuronal signal 
transduction, cellular or physiological responses can vary based on the cellular location of the 
signal initiation. The most widely studied endosomal signalling pathways in neurons involves 
neurotrophin response such as nerve growth factors (NGF), brain-derived neurotrophic factor 
(BDNF), neurotrophin-3 (NT3) and NT4. All these proteins bind and activate specific Trk 
receptors, belonging to receptor tyrosine kinase families. Neurotrophin-Trk endosomes are 
internalized and able to activate different intracellular pathways like phosphatidylinositol 3-
kinase mediated pathways (PI-3 kinase), Ras/MAPK mediated pathways, and phospholipase 
Cγ (PLCγ) mediated pathways (Yamashita & Kuruvilla, 2016). Trk receptors that are bound to 
neurotrophic factors will initiate the formation of clathrin-mediated endosomes. The activation 
of Trk receptor initiates a cascade of molecular events and among them is a binding of 
phospholipase Cγ (PLCγ) which facilitates a recruitment of components of endocytic 
machinery (Bodmer, Ascan, & Kuruvilla, 2011). The internalized Trk receptor remains 
bounded to neurotrophic molecules, also tyrosine phosphorylated and the interior of the vesicle 
contains number of signalling molecules such as PLCγ, PI3 kinase and proteins of MAP kinase 
pathway. The vesicle is then transported to the soma through the micotubule-dynein retrograde 
  
7 
 
transport (Du et al., 2003; Yamashita & Kuruvilla, 2016). This enables neurotrophins to act on 
long-range signalling and also affect transcriptional events (Cosker & Segal, 2014).  
  Endocytosis at the synapses have a crucial role. When the neurotransmitters are released in 
the synaptic cleft by exocytosis, it is followed by a fast retrieval of constituent membranes and 
proteins. Two mechanisms have been identified in vesicle retrieval: clathrin-mediated 
endocytosis and bulk retrieval (Royle & Lagnado, 2003). Several studies have shown that the 
time scale of these two mechanisms are much different (Figure 1.3) (Xue et al., 2012). The bulk 
endocytosis or a clathrin-independent endocytosis is termed as a fast mode and the process takes 
about a second. The clathrin-mediated endocytosis, on the other hand, is described as a slow 
mode taking about tens of seconds (Gross & Gersdorff, 2016).  
 
 
Figure 1.3. Figure illustrating endocytosis and exocytosis at nerve terminals. In exocytosis, synaptic vesicles (red 
circles) fuse with the cell membrane at active zone (AZ) and release neurotransmitters (red and grey dots) to the 
synaptic cleft. SVs that are fused are then recycled to create a new storage of readily releasable SVs at AZ. 
Recycling involves two processes: fast endocytosis and slow endocytosis and both pathways require protein 
transporters and clathrin-mediated endocytosis to create new synaptic vesicles (Gross & Gersdorff, 2016). 
 
  Different authors have shown that when neurons are moderately stimulated there are both slow 
and fast mode of endocytosis present in the nerve terminals, but the contribution of fast 
endocytosis increases progressively by stronger stimulus (Renden & Gersdorff, 2020). But 
when stronger and more prolonged stimulus is present, the fast mode of endocytosis, a clathrin-
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independent pathway, dominates (Okamoto et al., 2016). Additionally, it has been shown that 
mitochondrial Ca2+ uptake is related to the presynaptic endocytosis. A study published in 2016 
(Roslin et al.) demonstrated that the synaptic vesicle endocytosis increases when the 
mitochondrial calcium uniporter (MCU) channel is blocked and slows down when MCU was 
overexpressed. MCU is the primary calcium channel in mitochondria that is responsible for 
accumulating calcium ions in mitochondria at presynaptic terminals. The reason of this relation 
is still not clear but can be explained in the following way: ablation of calcium storage increases 
the acidification in the cytosol and synaptic vesicles which in turn enhances the endocytosis of 
synaptic vesicles. Authors of the given report also pointed out that it also shows a direct 
interaction between mitochondrial calcium uptake and SV endocytosis. This hypothesis could 
be supported by the close proximity of mitochondria and transmitter vesicles in presynaptic 
terminals where chemical changes can have a rapid effect on vesicles kinetics (Marland et al., 
2016).  
 
 
1.3. Intersectins family and their role in clathrin-mediated 
endocytosis 
 
  As it was mentioned earlier, ITSNs have been shown to mediate endocytosis. Besides that, 
ITSNs have a regulatory role also in signalling pathways such as MAPK and interact with 
family of Ras GTPases. Additionally, they are one of the regulators of actin cytoskeleton 
rearrangement and act as a bridge between receptor tyrosine kinase signal transduction 
pathways and clathrin-mediated endocytic internalization pathways (Herrero-Garcia & Bryan, 
2018). Nevertheless, the best known function that most of the studies have focused on is the 
ITSNs interactions with endocytic complex where they function as adaptor and scaffold 
proteins for other relevant biomolecules that bind to the site (Wong et al., 2012).  
 
1.3.1. Genetics and structure of intersectins 
 
  ITSNs are highly conserved proteins in all metazoans with orthologs from nematodes to 
mammals. In vertebrates, there are two genes that encode those proteins - ITSN1 and ITSN2 
genes. ITSN1 gene is located on the Chromosome 21 and ITSN2 located on the Chromosome 2. 
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There are two main isoforms of both ITSN1 and ITSN2 – a short (ITSN1/2-S) and a long 
(ITSN1/2-L), which are generated by alternative splicing (Herrero-Garcia & Bryan, 2018). The 
two main isoforms encoded from ITSN1 gene are respectively 1220 (ITSN1-S) and 1721 
(ITSN1-L) amino acids long (Guipponi et al. 1998). While the main isoforms from gene ITSN2 
are 1249 (ITSN2-S) and 1696 (ITSN2-L) amino acids long (Pucharcos et al. 2000). 
  All ITSN isoforms contain two Eps15 homology (EH) domains that binds the epidermal 
growth factor receptor (Confalonieri et al. 2002). EH domain interacts with target proteins such 
as Epsin that contain a three amino acid motif Asp-Pro-Phe (NPF) motif. There are also 5 
repeats of Src homology 3 domains (SH3) that have a variety of functions in endocytosis. For 
example, it is responsible for binding to dynamin, synaptojanin, actin and it is involved in cell 
signalling in general (Herrero-Garcia & Bryan, 2018). Between these two regions there is a 
domain called coiled-coil (CC) that promotes homo-and heterodimerization of proteins 
(including ITSNs) through the hydrophobic forces between α-helices (Figure 1.4). Several 
sequential repeats of α-helices coil together and form a structurally very stable arrangements 
that resemble a bundle of rope (Liu et al., 2006).  
  Long isoforms of ITSNs (ITSN-L) have three additional domains in their structure: Dbl-
homology (DH) domain, pleckstrin-homology (PH) domain and C2 (Ca2+ binding) domain 
(Figure 1.4). DH and PH domains interact with Rho-family GTPases. Although it is 
characterized as a lipid binding region, in the case of ITSN1/2-L these domains have been 
shown to specifically bind and activate Cdc42 which is also a Rho-familiy GTPase. Cdc42 is 
known as an important regulator of cell cycle and cell division. Finally, the C2 domain is also 
partially implicated in GTPase regulation and membrane trafficking. (Chhatriwala et al. 2007; 
Herrero-Garcia & Bryan, 2018).  
  Previous studies have shown that the majority of ITSN1/2 isoforms (ITSN1-S, ITSN2-S, 
ITSN2-L) are ubiquitously expressed in many tissues and localized throughout the cytoplasm 
or in a perinuclear region (Herrero-garcia & Bryan 2018). However, ITSN1-L is shown to be 
expressed predominantly in brain (Hussain et al., 1999).   
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Figure 1.4. ITSN orthologs, isoforms and domain composition. ITSN proteins in different species (C. elegans, D. 
melanogaster and H. sapiens) have similar domain composition with conservative protein sequences. All ITSNs 
have EH (Eps15 homolgy), SH3 (Src homology 3) and coiled-coil domains. ITSN-L in H.sapiens additionally 
have C2 (Ca2+ binding), PH (pleckstrin homology) and DH (Dbl homology) domains (Gubar et al., 2013). 
 
1.3.2. Function of Intersectins in neuronal clathrin-mediated 
endocytosis 
 
  As it was mentioned earlier, the best studied functions of ITSNs are their role in clathrin-
mediated endocytosis. ITSNs constitute a part of the initiation complex and help to recruit 
essential proteins to the machinery of endocytosis, namely, dynamin, Epsin2, Eps15, Eps15L, 
clathrin, synaptojanin2b, Cdc42, amphiphysin, SNAP29, HIP1, Dab2, AP2 and REPs. 
Intersectins can also participate in GTPase activation through the DH-PH domains (Wong et 
al., 2012). Genetic studies have revealed that loss-of-function mutations in C. elegans ITSN 
orthologs can cause a reduced density of vesicles in synaptic terminals. That in turn suggest 
that ITSNs play a role in recycling of synaptic vesicles (SVs). In mammals, silencing of ITSNs 
lead to the defects in endocytosis although not lethal. Interestingly, in Drosophila, knock-out 
mutations in ITSN homologue dap160 lead to the death of an animal (Herrero-garcia & Bryan 
2018).  
  While ITSN1-L isoform expression is neuron specific, ITSN1-S is also found to be expressed 
in the brain but restricted to glial cells (Yu et al., 2008). Important to note that ITSN1-L 
knockdown studies have been observed no differences in synaptic vesicle (SV) recycling in 
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pre-synaptic hippocampal neurons compared to wild types. Additionally, double labelling 
immunofluorescence with antibodies against synaptophysin, an established marker of synaptic 
boutons, have shown little or no localization of intersectin1-L in axonal terminals. This data 
suggests that intersectins are not present in pre-synaptic axonal boutons in mammalian 
hippocampal neurons (Ritter et al., 2009). Contrary to these statements, in 2017, researchers 
from Yale University demonstrated exactly opposite data (Gerth et al., 2017). Gerth and his 
colleagues screened the presynaptic endocytic machinery in hippocampal neurons with mass 
spectrometry and immunoblotting and observed the presence of ITSN1-L in the nerve 
terminals. The main difference with previous study lays down in the usage of antibodies against 
presynaptic protein synapsin I that is known to be an abundant presynaptic protein. 
Immunoblotting revealed ITSN1-L as a synapsin binding partner that co-localizes at the 
synapses of hippocampal neurons. Further investigation showed that synapsin I binds to the 
SH3-A domain of intersectin 1-L. Mouse models with intersectin 1 and intersectin  2 double 
knockouts demonstrated that there were no significant differences in the total synaptic vesicle 
(SV) densities of docked SVs which is also consistent with the previous study. Additionally, 
double knockouts demonstrated the shift of the synapsin I localization from the centre of active 
zone at presynaptic terminals. This data suggested that intersectins at presynatpic terminals 
regulate the nanoscale distribution of synapsin I at the active zone and subsequently control the 
SV replenishment from the reserve pool at mammalian synapses (Gerth et al., 2017). The role 
of ITSN1-L or ITSNs in general at the presynaptic terminals still remains an open and ongoing 
question, but latest studies tend to suggest that ITSNs are indeed present at the site and therefore 
need to have a function there.  
  Currently, localization of ITSN1-L at the postsynaptic dendritic spines and somas is an 
established concept. Previous studies have found that intersectins co-localize with AP2 protein 
in dendrites and clathrins at the clathrin-coated pits in a somatodendritic regions. Analysis of 
the rate of clathrin-mediated endocytosis with transferrin has additionally demonstrated that 
hippocampal neurons with ITSN1-L knockdowns have a significant reduction in transferrin 
uptake and a constitutive endocytosis in dendrites and somas. Obtained results strongly indicate 
that ITSN1-L functions in a clathrin-mediated endocytosis between dendritic spines and somas. 
Lastly, loss-of-function studies have demonstrated that ITSN1-L knockdown neurons have an 
increased number of long, thin and morphologically immature looking spines compared to wild 
type ones. These data suggests the influence of intersectins on the maturation of dendritic spines 
in brain tissue (Ritter et al., 2009).  
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  Besides interacting with AP-2 and clathrin, another important binding partner is a protein 
Numb. This protein is shown to be localized in dendritic spines where it regulates spine 
development in hippocampal neurons as well as promotes neuronal polarization. Numb binding 
with ITSN1-L stimulates GTPase activity by interaction with Cdc42 which is consistent with 
the fact of an essential role of Cdc42 as part of a family of small GTPases that are essential in 
axonogenesis and neurite outgrowth during brain development (Hall & Lalli 2010; Herrero-
Garcia & Bryan 2018).  
 
 1.3.3. Role of intersectins in neurodegenerative diseases 
 
  Due to their role in initiating clathrin-mediated endocytosis, ITSN1-L and ITSN-S are 
associated with multiple neurodegenerative diseases, primarily the Down Syndrome (DS) 
phenotype and Alzheimer’s Disease (AD). ITSN1 is located on the chromosome 21q22.2 which 
is the region closely linked to DS. In DS, ITSN1 has three copies and resulting in overexpression 
of ITSN1-S. Additionally, ITSN1 gene localizes in close proximity to amyloid β gene, which is 
also overexpressed in DS patients resulting in the development of AD-like neuropathology in 
mid-life which manifests in cognitive decline (Herrero-Garcia & Bryan, 2018; Rembach et al. 
2019).  
  The research, on whether ITSN1 is a causative factor in these pathologies, is still on going and 
it is still not clear if ITSN1 actually causes neuronal disorders. Different reports and data can be 
contradictory (Scappini et al. 2007; Nixon, 2005; Wilmot et al. 2008; Rembach et al. 2019) or 
focus on different aspects on this issue. Transcriptional study on ITSN1 expression and 
cognitive decline have identified significant upregulation of this gene but interestingly it has 
been seen specifically for short isoform, ITSN1-S. On the same study, this transcript was 
confirmed to be upregulated in AD models (Wilmot et al., 2008).  
  In the study published in 2019, protein expression levels of ITSN1-S and ITSN1-L isoforms 
in human post-mortem brain tissues were analysed. No differences between the levels of ITSN1 
proteins (both L and S isoforms) in frontal and temporal cortices of AD patients compared to 
the healthy control ones was reported in this study (Malakooti et al., 2019).  
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1.4. microRNAs: biogenesis, mechanism of action and 
dysregulation in neurodegenerative diseases 
 
  MicroRNAs (miRNAs/miRs) are a large group of non-coding RNAs that regulate the 
expression of many protein-coding genes by binding with messenger RNAs (mRNAs). 
miRNAs were discovered in 1993 (Lee et al. 1993) although their function as regulators of gene 
expression and involvement in RNA interference (RNAi) was first observed in late 1990s (Fire 
et al. 1998) which later brought a major shift in our understanding of gene regulation and Nobel 
prize in medicine and physiology to the authors. More than a decade of microRNA research has 
demonstrated that these small non-coding RNAs are extensively used by living organisms to 
regulate gene expression (O’Brien, Hayder, Zayed, & Peng, 2018).  
  Mature miRNAs are short non-coding molecules with an average length of 22 nucleotides 
(Weiss & Ito, 2018). miRNA maturation usually includes several processing steps. Firstly, they 
are transcribed from miRNA-coding genes as relatively long (several hundred nucleotides) 
primary miRNAs (pri-miRNA) by RNA polymerase II or III (O’Brien et al., 2018). In some 
cases, pri-miRNAs can be transcribed as one long transcript containing several mature miRNA 
sequences, called miRNA cluster (Kabekkodu et al., 2018). Next, pri-miRNAs are processed 
by microprocessor complex containing RNA binding protein DGCR8, which recognizes the 
RNA, and ribonuclease III enzyme Drosha that cleaves pri-miRNA duplex at the base of its 
hairpin structure. The resulting 70 to 100 nucleotides molecule, pre-miRNA, is exported to the 
cytoplasm by exportin5/RanGTP complex with subsequent cleavage by RNAse III 
endonuclease Dicer. Endonuclease removes the loop structure from the molecule resulting in a 
mature microRNA molecule. The final cleavage creates two single strands of miRNA – with 
the first one generated from the 5’ end of pre-miRNA (5p strand) while the second comes from 
the 3’ end (3p strand). Next, mature miRNA has to bind with Argonaute protein to guide the 
regulation of mRNAs. In principal, both strands can be loaded onto the Argonaute (AGO) 
protein but usually the strand with lower 5’ stability is loaded into AGO and guides Argonaute 
to the target messenger RNA that contains complementary sequence to the miRNA seed region 
while the second strand is degraded (O’Brien et al., 2018). 
   The complex of miRNA guiding strand and AGO is called miRNA-induced silencing 
complex (miRISC) and the complex can either silence gene expression by inhibiting protein 
translation or by promoting mRNA decay (Behm-Aansamant et al. 2006). The degree of 
complementary of guiding strand to target mRNA determines whether the target strand is 
degraded by AGO2-dependant manner or translationally inhibited by miRISC complex. In 
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mammals, most of miRNA and target interactions are not fully complementary which means 
they are only translationally inhibited. Most of the studies have also shown that miRNAs bind 
to the specific sites at 3’ untranslated region (UTR) of target mRNA. The binding to the 3’UTR 
induces translation downregulation of the given mRNA. Other binding sites for miRNA, but 
less important, can be located at 5’UTR, coding region and also promoter region in DNA. 
Binding to 5’UTR or coding region also exhibits silencing effects on the mRNA. On the other 
hand, interaction with promoter region induces transcription (O’Brien et al., 2018). 
  miRNA systematic studies have demonstrated that many miRNAs are significantly up- or 
downregulated in many neurodegenerative diseases such as amyothrophic lateral sclerosis 
(ALS), Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease and multiple 
sclerosis. The dysregulation of miRNAs in turn disrupts the regulation of receptors and 
enzymes. Previous studies have shown the interactions between miR-21-5p and amyloid-β, α-
synuclein and T-cell activation. Also, regulations of NF-κB by miR-146a-5p and glutamate 
receptor subunit GluR2 by miR-223-3p have been demonstrated (Juźwik et al., 2019).  
   So far, little is known about the intersectins regulation and the effect of miRs on the 
expression of intersectins. The aim of our study was to investigate the regulation of ITSNs by 
microRNAs in HEK293T and human neuronal cell culture.  
 
Aims of the study 
 
The objectives of the study were following: 
• Create plasmid luciferase reporter constructs bearing 3’UTRs of ITSN genes and 
microRNAs. Transfect HEK293T cells with constructed plasmids and analyse the 
expression levels of luciferase, reflecting on which microRNAs have the most 
significant down or upregulating effect on 3’UTRs. 
• Construct lentivirus particles containing microRNAs. Transduce human neuronal cell 
cultures with virus particles and analyse intersectins transcripts (mRNA) levels by RT-
qPCR. 
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2. Materials and Methods 
 
2.1. Culturing of cell lines 
 
2.1.1. HEK 293T 
  
  Human embryonic kidney (HEK) 293T cell line was cultured in a DMEM growth medium 
(Dulbecco’s modified eagle’s medium), 10% of fetal bovine serum (FBS) and 0.1 mg/ml of 
normocine antibiotic to prevent bacterial contamination and mycoplasma growth. Before 
passaging, the cells were washed with 4 mL of 1x phosphate-buffered saline (PBS) solution. 
Then, the cells were treated with 1 ml of trypsin for 2 minutes to detach them from the surface 
of a culturing flask and suspended in DMEM media 2x of the volume of trypsin. Cell cultures 
were incubated either in 50 ml culturing flask or in 10 cm Petri dish (Cellstar) in a cell culture 
incubator at 37°C and 5% CO2. 
 
2.1.2. Human neuronal stem cells 
 
  In addition to HEK293T cell line, we used human neuronal stem cells (NSCs) derived from 
cell line HEL47.2. This human iPSC cell line was derived from the dermal fibroblasts of the 
83-year old male (Trokovic et al. 2015). NSCs were first cultured on a 3.5 cm Petri dishes and 
then passaged on the 12-well plate. First, the wells were coated with basement membrane 
matrix. Corning MatrigelTM GFR membrane matrix aliquots (100 µl) were dissolved in a cold 
DMEM/F12 medium in a ratio of 1:200. 1.5 ml of the solution was added to the 3.5 cm Petri 
dishes and 1 ml to each well in 12-well plates. NSCs were cultured in a neuronal differentiation 
medium (NDM) [DMEM/F12 and Neurobasal medium (Gibco) in a ratio 1:1, B-27 (1:100) 
(Gibco), N-2 (1:200) (Gibco), 2mM of glutaMAX (Thermo Fisher Scientific) and 10 µg/ml of 
Penicillin-Steptomycin (PenStrep, Thermo Fisher Scientific) antibiotics]. After thawing of 
NSCs vials from liquid nitrogen, they were gently transferred into 4 ml of NDM medium and 
centrifuged at 500 rpm for 5 minutes. Then, discarding supernatant, resuspending the pellet in 
1 ml of NDM and adding 10 µM of ROCK inhibitor (Rho kinase inhibitor). Finally, cell 
suspension was gently pipetted to the prepared Petri dishes. Next day, the medium was changed 
to remove dead cells and ROCK inhibitor.  
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  Before passaging to the 12-well plates, NSCs were incubated for 3-5 days to form networks. 
The time period between the passaging of NSCs from 3.5 cm dishes to 12-well plate was 
estimated based on the cell recovery which was assessed under the microscopy DM IL (Leica, 
Germany). NSCs were let to mature and grow processes which assured that they were indeed 
in good condition which approximately took 3-5 days. Dishes with the NSCs were first washed 
with 1 ml PBS, then treated with 1 ml of accutase and incubated for 8 minutes at 37°C. Then 
accutase-treated cells were carefully rinsed with 3x1 ml of NDM per dish to detach cells from 
the matrix, transferred to the 15 ml Falcon tubes and centrifuged at 300 x g for 3 minutes. The 
pellet was resuspended in 1-3 ml of NDM and slowly pipetted up and down. Then, cell 
suspension was pipetted through the cell strainer, to get rid of cell clumps. After that, 10 µl of 
cell suspension was mixed with 10 µl of trypan blue (Thermo Fisher Scientific) and taken to 
the haemocytometer to calculate an approximate number of cells. For culturing cells, cell 
density should be approximately 100000 cells/cm2. Meaning, in one well, in 12-well plate with 
well radius of 1.105 cm, the approximate number of cells would be 400000 million of cells per 
well. The medium was changed every 2-3 days. 
 
2.2. Design of primers and plasmids 
 
2.2.1. Design of miRNA oligonucleotides and 3’UTRs cloning primers 
 
  Primers for both miRNAs and 3’UTR regions of intersectins were ordered from Metabion 
International AG (Germany) in lyophilized or water-diluted form (100 µM concentration). 
Primers for 3’-untranslated regions (3’UTRs) were designed to clone 3’UTRs of ITSN2, 
ITSN1-L and ITSN1-S. Because ITSN1-L has exceptionally long 3’UTR region (11556 bp) 
(Kropyvko, 2010), it was divided into three segments – ITSN1-LA, ITSN1-L-B and ITSN1-L-
C. Therefore, primers were separately designed for each part of ITSN1-L 3’UTR region to clone 
them separately to the expression vectors. To obtain 3’UTRs from the human male genomic 
DNA (Promega, USA), PCR reaction with H2O, 1xHighFidelity (HF) buffer, 1 µM dNTP, 10 
µM forward and reverse primers, Phusion DNA pol (Thermo Fisher Scientific) and template 
DNA was performed with the following program parameters: denaturation at 98°C for 10 
seconds, annealing at 60°C for 20 seconds, and elongation at 72°C for 30 seconds, which was 
repeated in 25 cycles (SimpliAmp Thermal Cycler, Applied Biosystems). After that, samples 
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were cooled down to 4°C and stored at -20°C. The sequences of all primers are shown in Table 
1.1. 
Primers of 3’UTR 
regions 
Sequences (5'-3') 
3'UTR ITSN1-S 
For 
TAGGCGATCGCTCGAATCATATGTTGTCCATCCC 
3'UTR ITSN1-S 
Rev 
TTGCGGCCAGCGGCCTAACTTTTGTATGAAGAATTTAA 
3'UTR ITSN1-L A 
For 
TAGGCGATCGCTCGAGCAGCGGGCTCAGGGTGT 
3'UTR ITSN1-L A 
Rev 
TTGCGGCCAGCGGCCCCTCTTATGGTGGCTCAGACT 
3'UTR ITSN1-L B 
For 
TAGGCGATCGCTCGACCTTGTATAAGCAGAAAAAGACTTC 
3'UTR ITSN1-L B 
Rev 
TTGCGGCCAGCGGCCGAGCTCAATGGTAAAGGCTCAC 
3'UTR ITSN1-L C 
For 
TAGGCGATCGCTCGAGTTGCTCCACAGTCCTGTC 
3'UTR ITSN1-L C 
Rev 
TTGCGGCCAGCGGCCTTGGCTTTTCTCCTTTTATTCATG 
3'UTR ITSN2 For TAGGCGATCGCTCGAGGGTTCTAAAGGACAGCAC 
3'UTR ITSN2 Rev TTGCGGCCAGCGGCCTTCCATCCATAAACATATGTCTTT 
 
Table 1.1. Primers to amplify 3’UTR’s of ITSN genes. Amplified regions were then ligated to the 
psiCHECK™2 Vector (Promega, USA). 
  
  MicroRNA single stranded oligos were designed for human microRNAs: miR-30a-5p, miR-
19, miR-124-3p, miR-128, miR-181a-5p and for miR-218 and ordered from Metabion 
International AG (Germany) in lyophilized of 100 µM water-diluted form. Sequences of 
microRNA oligos are shown in the Table 2. 
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Primer for 
miRNA 
cloning 
Sequences (5'-3') 
miR-30a-5p 
top 
TGCTGTGTAAACATCCTCGACTGGAAGGTTTTGGCCACTGACTGA
CCTTCCAGTGGATGTTTACA 
miR-30a-5p 
bottom 
CCTGTGTAAACATCCACTGGAAGGTCAGTCAGTGGCCAAAACCT
TCCAGTCGAGGATGTTTACAC 
miR-124-3p 
top 
TGCTGTAAGGCACGCGGTGAATGCCAAGTTTTGGCCACTGACTG
ACTTGGCATTCGCGTGCCTTA 
miR-124-3p 
bottom 
CCTGTAAGGCACGCGAATGCCAAGTCAGTCAGTGGCCAAAACTT
GGCATTCACCGCGTGCCTTAC 
miR-181a-
5p top 
TGCTGAACATTCAACGCTGTCGGTGAGTGTTTTGGCCACTGACTG
ACACTCACCGACGTTGAATGTT 
miR-181a-
5p bottom 
CCTGAACATTCAACGTCGGTGAGTGTCAGTCAGTGGCCAAAACA
CTCACCGACAGCGTTGAATGTTC 
 
Table 1.2.   Oligos for microRNA cloning. Single-stranded oligos were used to generate double-stranded ones 
that were then ligated to the pcDNA6.2-GW/EmGFP vector backbone.  
 
2.2.2. Construction of miRNA expressing plasmids 
 
  For microRNA cloning, top and bottom single-stranded oligos for each microRNA were 
annealed to generate double-stranded insertion containing microRNA sequence (Table 1.2). For 
annealing single-stranded oligos, 50 µM of both top and bottom strand, 1x annealing buffer 
(10x) (10 mM Tris, 50 mM NaCl, 1 mM EDTA) were added to the reaction, which was 
incubated on a thermomixer 5436 (Eppendorf, Germany) for 4 minutes at 95°C. After 
incubation, the reaction was cooled down to room temperature (RT) and stored in a freezer at -
20°C. Double-stranded miRNA oligos were ligated to the commercially available expression 
vector pcDNATM6.2-GW/EmGFP (Figure 1.3) (Invitrogen, Thermo Scientific, USA). The 
given vector simultaneously expresses Emerald Green Fluorescent Protein (EmGFP) which 
allows to track cells under fluorescence microscopy (EVOSTM FLoid Thermo Fisher Scientific, 
USA) that express given expression vector. A ligation reaction was preformed with the 
following reagents: 1x ligation buffer (10x) (50 mM Tris-HCl, 10 mM MgCl2, 1 mM ATP, 10 
mM DTT), 1 µl of pcDNATM 6.2GW/EmGFP expression vector, 10 µM double-stranded oligos 
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and 1 U/µl of T4 DNA ligase in milliQ water and incubated at RT for 30 minutes and used for 
E. coli transformation.  
 
 
Figure 1.3. pcDNATM6.2-GW/EmGFP-miR vector for microRNA expression. Selected microRNA sequences 
were ligated in the region depicted above using sticky ends of ACGA and CAGG. EmGFP gene (Emerald Green 
Fluorescent protein) expression was used to confirm successful transfection of the construction in transfected cells 
under green light. Spectinomycin resistance gene was used to selectively cultivate E.coli cells transformed with 
the given vector (InvitrogenTM, 2010).  
 
2.2.3. Construction of plasmids bearing 3’UTRs of ITSN1/2 
 
  For the expression of ITSN 3’UTRs (target DNA), I used a commercial psiCHECK™-2 
Vector (Promega), which is optimized to perform RNAi assays (siCHECK™ Vectors, 2016). 
After performing PCR with target primers, PCR products were run on 1% agarose gel [≈0.5 
μg/ml ethidium bromide, 1xTAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA) for 
150 ml] to visualize the PCR products under UV-light and excise appropriate bands from the 
gel. 
  PCR fragments were then extracted from the gel using a commercial NucleoSpin Gel and PCR 
Clean-up kit (Macherey-Nagel). First, NTI solution was added to the gel fragments with a 2x 
volume (µl) of the mass (mg) of the gel fragments. Gel fragments with NTI solution were then 
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incubated at 50°C for 10 minutes and transferred to the NucleoSpin extraction column tubes. 
Tubes were spinned in a centrifuge 5702 (Eppendorf) for 30 seconds at 11 000 g. Then washed 
3x with 700 µl of NT3 solution and centrifuged again after each wash at the same parameters. 
Then, columns with PCR products were dried by centrifugation without adding any solution 
and heated for 2 minutes at 70°C on a Thermomixer 5436 (Eppendorf). To elute DNA from 
columns, 30 µl of pre-warmed elution buffer at 70°C were added, incubated for 5 minutes at 
70°C and centrifuged down at 11 000 g for 1 minute. The concentrations were measured on a 
spectrophotometer NanoDrop ND-1000 (Thermo Scientific, USA). 
  After gel extraction, PCR fragments were ligated to the psiCHECK™-2 expression vector 
(Figure 1.4) using a 2x NEBuilder High Fidelity (HiFi) DNA Assembly master mix (New 
England BioLabs Inc., USA). Then, 15-30 ng/µl of PCR fragments and 50 ng of linearized 
vector (treated by XhoI and NotI restrictases) were added to the master mix and incubated at 
50°C for 15 minutes. After incubation and cooling on ice, ligation mix was used for E. coli 
transformation immediately or stored at -20°C.   
 
 
Figure 1.4. PsiCHECK™-2 expression vector for cloning 3’UTRs of ITSN mRNAs. 3’UTRs were ligated to 
the vector linearized with NotI (1674) and XhoI (1643) restriction enzymes to be transcribed together with hRluc 
(Renilla luciferase) gene regulated by SV40 promoter. Selection of positive E. coli clones was performed using 
ampicillin resistance gene (Ampr) (siCHECK™ Vectors, 2016). 
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2.2.4. Construction of lentivirus transfer plasmids for miRNA 
expression 
 
  Lentivirus-based miRNA expressing vectors were made based on the pCDH-hSYN backbone 
with a human synapsin (hSyn) gene promoter characterized by highly neuron-specific long-
term transgene expression properties. hSyn promoter can restrict transgene expression only to 
neurons (Kügler et al. 2003). EmGFP-miRNA region, obtained from the pcDNATM6.2-
GW/EmGFP-miR vector (Fig. 1.3), was ligated to the backbone to express selected miRs and 
Emerald Green Fluorescent Protein (EmGFP) to confirm microRNA expression under 
fluorescence microscopy EVOSTM FLoid (Thermo Fisher Scientific, USA). pCDH-hSyn-MCS-
T2A-EGFP plasmid was digested with BamHI and SalI restriction enzymes. Digestion reaction 
contained 1xFD buffer (Fast Digest, Thermo Fisher Scientific), 0.5 µl (0.5 U) of restriction 
enzymes and 3 µl of target plasmid that were diluted in water to obtain 15 µl of final volume of 
the reaction. The reaction mixture was incubated at 37°C for 30 minutes and then run on 1% 
agarose gel electrophoresis (1xTAE buffer, ≈0.5 μg/ml ethidium bromide). The correct band 
from the gel was then excised and purified using the same manual from the NucleoSpin Gel 
and PCR Clean-up kit (Macherey-Nagel) as described above. Next, EmGFP-miR region from 
the pcDNATM6.2-GW/EmGFP-miR vector was amplified in PCR reaction with primers listed 
in the Table 1.5 to ligate it to the backbone. Obtained PCR fragments were then ligated to the 
purified and linearized backbone using 2x NEBuilder High Fidelity (HiFi) DNA Assembly 
master mix (New England BioLabs Inc., USA) as described above and transformed to the NEB 
5-α competent E.coli cells (New England BioLabs Inc., USA). Positive clones were selected 
and used for plasmid DNA isolation with subsequent digestion analysis and sequencing to 
confirm successful construction of the new miRNA-bearing plasmids. In total, constructions 
bearing hsa-miR-181a-5p, hsa-miR-30a-5p, hsa-miR-124-3p and negative control microRNA 
(does not target any known gene in the human genome) were generated. 
 
Primers for 
EmGFP-miR 
region 
Sequence (5'-3') 
EmGFP For GTATAAACTTAAGCTTCACCATGGTGAGCAAGGGC 
miR Rev CAGCGGGTTTAAACGGGCCCCTCGAGTGCGGCCAGATCT 
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Table 1.5. Primers to amplify EmGFP-miR region from pcDNATM6.2-GW/EmGFP-miR vector. Both 
primers have overlaps of 15 nucleotides (nt) with the pCDH-hSyn backbone. Successful recombination of the 
EmGFP/miRNA sequence with pCDH-hSyn vector caused deletion of BamHI restriction site with keeping SalI 
restriction site in the final construct. 
 
2.3. Transformation 
 
  After obtaining correct expression vectors, they were used for transformation of Escherichia 
coli (E.coli). For the transformation, we used 50 µl aliquots of NEB 5-α competent E.coli cells 
(New England BioLabs Inc., USA). 1-2 µl of plasmids were added to the aliquot and left on ice 
for 30 minutes. Then, placed to the heat block for 45 seconds (at 42°C) and put back on an ice 
for 5 minutes to recover. After that, we added 450 µl of SOC outgrowth medium (New England 
BioLabs Inc., USA) and incubated for 1 hour at 37°C on a shaker Thermomixer 5436 
(Eppendorf AG, Germany). 
  After incubation, the suspension was plated on 10 cm Petri dishes with LB medium (lysogeny 
broth). miRNA-containing vectors were plated on LB dish with 0.05 mg/ml spectinomycin 
antibiotic while vectors with fragments of 3’UTRs were plated on dishes containing 0.1 mg/ml 
ampicillin in LB agar. All dishes were incubated on 37°C for overnight. Next day, a single 
colony was taken out from the dish and inoculated to 2 ml liquid LB medium (0.1 mg/ml 
ampicillin or 0.05 mg/ml spectinomycin) and incubated overnight on 37°C on a shaking 
platform Polymax 1040 (Heidolph, Germany). 
 
2.4. Isolation of plasmid DNA, digestion analysis and 
sequencing 
 
  Plasmid DNA was isolated using a NucleoSpin Plasmid kit (Machery-Nagel, Germany). After 
overnight growth, the cell cultures were transferred to 2 ml Eppendorf tubes and centrifuged at 
11 000 g for 1 minute. Supernatant was removed and 250 µl of A1 (+RNAse) solution was 
added to the cell pellet. Then, it was briefly vortexed to mix it and 250 µl of A2 buffer was 
added to the mixture. Samples were then incubated at RT for 5 minutes. After that, 300 µl of 
A3 solution was added and the mixture was shaken in hand untill it turned colourless. Then, 
samples were centrifuged in a Heraeus Pico 17 centrifuge (Thermo Scientific, USA) for 5 
minutes at 11000 g. After centrifugation, plasmid DNA remained in a supernatant was 
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transferred to the NucleoSpin column tubes. Next, the samples were centrifuged again at same 
conditions for 1 minute. The flow-through in a collecting tube was discarded and 500 µl of AW 
(washing) buffer was added to the columns. It was again centrifuged at same conditions as 
before and flow-through was again discarded. Now, 600 µl of A4 (with ethanol) buffer was 
pipetted to the columns and samples were centrifuged again. After that, the supernatant was 
discarded again and the samples were centrifuged once again (2 minutes, 11 000 g) to dry. 
Finally, the columns were carefully transferred to 1.5 ml Eppendorf tubes and 50 µl of AE 
(elution) buffer was pipetted to the column filters. Then, samples were incubated for 2 minutes 
on 70°C and centrifuged down at 11 000 g for 1 minute to elute plasmid DNA. The 
concentration of DNA was measured on a NanoDrop ND-1000 (Thermo Scientific, USA). 
 
2.5. Transfection of HEK293T 
 
  When HEK293T cells became confluent on the 96-well plate they were ready to be 
transfected. The transfection scheme was made so that the final concentration of the 3’UTR and 
the microRNA-containing plasmids were both 500 ng/µL per well. Before adding vectors with 
target 3’UTRs and miRNAs to the plate they were all diluted to 100 ng/µL. The final volume 
of transfection mix in luciferase assays was 100 µl per well therefore there was 200 ng of DNA 
(1:1 of target DNA and miR) per well. Transfection mix included 0.4 µL of polyethyleimine 
(PEI), 25 µL of OptiMEM (optimal minimal essential medium) and 72.6 µL of DMEM (10% 
FBS) per well. After adding the transfection mix, cells were incubated for 48h at 37°C. 
 
2.6. Production of lentiviral particles 
 
  In order to produce effective virus particles able to infect NSC we used a 3rd generation of 
Lentivirus production system with an addition of pAdVAntageTM vector (Promega, USA). This 
vector was included to the system because it expresses adenoviral virus associated I (VAI) RNA 
to enhance protein expression in mammalian cells. The Lentivirus production system included 
three plasmids. First vector pMDLg/pRRE was needed to express polymerase (HIV-1 POL) 
and inner shell proteins (HIV-1-GAG). Second one, pRSV/REV, expressed a Rev protein which 
helps to relocate newly transcribed HIV mRNA to cytoplasm. Otherwise, it would stay in 
nucleus and the translation would be prevented. The last one, pMD2.G, expresses VSV 
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glycoprotein (VSV-G) (Gandara et al., 2018). Such complex system is necessary to create 
biologically safe replication-deficient lentiviral vectors, which can transduce, but unable to 
propagate, in target cells (Milone & Doherty, 2018).  
  First, we seeded HEK293T cell lines to the 10 cm Petri dishes (Cellstar) in 10 ml DMEM 
(10% of FBS, 0.1 mg/ml normocin) and 25 mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid). Cells were grown until 70-80% confluency. Vectors were 
added to the dishes so that the final amount of each vector is 2 µg per dish. The only difference 
was that the transfer vector had the amount of 4 µg per dish. DNA mixtures were mixed into 
the 500 µl of pre-warmed OptiMEM II medium. Then, 48 µl of PEI (diluted in 1xPBS) in a 
ratio of 4:1 (PEI:DNA) was added. Next, the solution was briefly vortexed and then left to 
incubate at RT for 5-10 minutes. After incubation, the transfection solution was pipetted to the 
cell cultures and dishes were swirled few times so that the media would distribute evenly. After 
about 72 hours of transfection, viruses were collected. Media was transferred to the 50 ml tubes 
and centrifuged at 200 g for 5 minutes in SL 16R centrifuge (Thermo Scientific, USA). Viruses 
would stay in a supernatant which was filtered through the 0.45 µm filter. Supernatant was then 
poured to the ultracentrifuge tubes (Beckamn UltraClear) and centrifuged in the Beckman AH-
629 rotor using EvolutionTM RC Superspeed Centrifuge (Sorvall, USA) for 1.5 hours at 25 000 
rpm 4°C. After that, the virus particles migrated to the bottom of the tubes. The supernatant was 
then discarded and the pellet was resuspended in 60 µl of sterile Dulbecco’s PBS. All 
resuspended pellets were then collected to a single 1.5 ml Eppendorf tubes and centrifuged on 
a benchtop centrifuge (Thermo Scientific, Pico 17) for 1 minute at maximum speed. Virus 
particles were stayed in a supernatant which was then collected and stored in -80°C in an aliquot 
tubes (11 µl per tube). 
 
2.7. Transduction of neuronal cells 
 
  Transduction of NSCs HEL47.2 was done by first taking away the old media. Pipetting was 
done very slowly and carefully so that neuronal cells does not detach from the matrix. The final 
volume of new NDM media was 1.5 ml per well. First, we added 750 µl of new media to each 
well. Then another 750 µl was first mixed with a 5 µl of Lentivirus aliquots in a separate 1,5 
ml Eppendorf tubes. The volume of virus stock (with the titer of »109 virus particles/ml) was 
calculated to obtain multiplicity of infection (MOI) of » 5, which theoretically should result in 
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transduction of 99.3% cells. After that, the mixture was also slowly pipetted to each well. Plates 
were then put back to the 37°C, 5% CO2 incubator.  
 
2.8. Dual-luciferase reporter assay 
 
  Dual-Luciferase Reporter (DLR) assay was performed using a commercial Reporter Assay 
System from Promega, USA. All reagents were prepared according the commercial manual of 
the kit. Transfected HEK293T cells were first lysed by 50 µl of passive lysis buffer (PLB) per 
well. Treated cells were then incubated in PLB solution for 15 minutes at room temperature on 
a shaking platform (PerkinElmer, United Kingdom). After that, a 10 µl from each well were 
transferred to the special 96-well plate, OptiPlate (PerkinElmer, USA) for luminescence 
measurements. For the measurements of luciferase activity, two reagents were used – luciferase 
assay reagent II (LARII) for firefly luciferase and Stop & Glow (S&G) reagent for the Renilla 
luciferase. LARII reagent was first diluted in 1:5 ratio in a sterile water. S&G reagent was first 
diluted in S&G buffer in a ratio of 1:50 and then diluted once more in sterile water in 1:5 ratio, 
so that the final ratio would be 1:250. Samples were then analysed in a multilabel analyser 
VICTOR3 (PerkinElmer, USA) with a Wallac 1420 workstation software.  
  psiCHECK™-2 vector encodes two different bioluminescence proteins, firefly (Photinus 
pyralis) and Renilla (Renilla reniformis) luciferase, which have evolutionary different origins 
and chemically different substrate requirements. Firefly luciferase gene is constitutively 
transcribed and translated and produces bioluminescence which, theoretically, does not depend 
on microRNA and, therefore, is used to normalize the signal between the wells (Fig. 1.5). The 
Renilla luciferase gene is ligated with our desired ITSN1/2 3’UTR sequences and they are 
transcribed as a single mRNA. So, when the cell lines, being transfected with both vectors 
psiCHECK™-2 and pcDNATM6.2-GW/EmGFP-miR, bearing particular microRNA, it should 
bind the hRluc-3’UTR mRNA and, downregulate the production Renilla luciferase protein 
which is fused with the target transcript (Fig. 1.4). As a result, it would manifest as a lower 
bioluminescence signal (Renilla luciferase) when compared to bioluminescence signal 
produced by firefly luciferase. In the DLR assay system, firefly luciferase activity is measured 
first as a reference luciferase activity by adding LARII to the wells and measuring the signal. 
Then, by adding Stop & Glow solution, firefly reaction is quenched and Renilla luciferase 
activity simultaneously initiated and measured (Technical Manual: Dual-Luciferase® Reporter 
Assay System, 2015). 
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Figure 1.5. Bioluminescent reactions catalysed by firefly and Renilla luciferases used in DLA. Firefly 
luciferase reaction requires ATP, O2 and Mg2+ and as a result one of the by-products is a flash of light. Renilla 
luciferase reaction requires only O2 and also produces a flash of light as a result (Technical Manual: Dual-
Luciferase® Reporter Assay System, 2015.).  
    
2.9. RNA isolation and RT-qPCR 
 
  The cells were lysed either by adding Laemmli buffer, for ITSN protein analysis, or TRI 
reagent (Thermo Scientific, USA) for ITSN mRNA analysis. For the latter, I started by isolating 
the total RNA. For the 12-well plate, I added 350 µl of TRI reagent solution per well. Then, 
pipetting the solution up and down for few times to detach the cells from the surface. After that, 
they were transferred to 1.5 ml Eppendorf tubes. At this point, the samples could be stored at -
80°C or continue with the isolation. Then, I added chloroform with a ratio of 1:5 to TRI reagent, 
shook it and then incubated for about 3 minutes at RT. After incubation, samples were 
centrifuged at 12 000 g’s for 15 minutes at 4°C (Heraeus Biofuge Fresco centrifuge, Germany). 
After centrifugation, two layers were visible with the white solid material between them. The 
upper, transparent layer was transferred to new 1.5 Eppendorf tubes and isopropanol was now 
added (1:2 volume of TRI reagent). Next, samples were incubated at RT for 10 minutes and 
centrifuged again at same conditions for 10 minutes. Now, a small amount of white pellet could 
be visible in the bottom of the tube. Most of the supernatant was removed and 75% ethanol was 
added to the tubes (1:1 ratio to trizole). Samples were mixed and spinned again at 4°C, 7500 g 
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for 5 minutes. Supernatant was discarded and samples were spinned once again for 1 minute at 
same conditions. Then, the rest of the supernatant was removed and tubes were let to dry at RT 
with open lids for about 10-15 minutes. After complete drying, the pellet was dissolved in 50 
µl of sterile RNAse-free water and stored at -80°C. Concentration of total RNA was measured 
on NanoDrop ND-1000 (Thermo Scientific, USA).  
  After measuring the concentrations of total RNAs we then synthesised complementary DNA 
(cDNA) in order to perform reverse transcription quantitative PCR (RT-qPCR) to assess 
miRNA and target expression. To synthesize cDNA for each miRNA, we used a TaqMan 
MicroRNA RT kit (Applied Biosystems, USA). Each RNA sample was synthesized in three 
technical repeats. The first one had a specific microRNA primer for the given miR, second one 
primer for negative control microRNA and third one as a negative control of cDNA synthesis 
(water). The reaction mix included 1 mM dNTP’s, 50 U/µl of MultiScribe RT enzyme, 1xRT 
buffer, 20 U/µl of RNAse inhibitor, U6 promotor 1xRT primer, water and specific miR 1xRT 
primer for the synthesis of specific microRNA cDNA. Lastly, we mixed it with 10 ng of RNA 
sample. Samples were then mixed and centrifuged briefly to spin down all the liquid drops and 
then run on a thermal cycler (SimpliAmp Thermal Cycler, Applied Biosystems, USA) in a 
following program: 30 minutes on 16°C, 30 minutes on 42°C, 5 minutes on a 85°C and finally 
cooled down to 4°C. When the program was done, the samples were diluted by adding 60 µl of 
sterile water. Now samples could be stored in -20°C or proceed with qPCR. For target synthesis 
(3’UTRs) we did not need to run it in triplicates. Samples from every miR were diluted to 500 
ng of total RNA, added to PCR tubes and then mixed with reagents. The reaction included 5 
mM oligo dT, 5 mM dNTP mix (Thermo Fisher Scientific, USA), 500 ng of total RNA sample. 
Then incubated at 65°C for 5 minutes. Then put back to the ice and added 1xRT buffer and 10 
U/µl of Maxima H Minus RT (Thermo Fisher Scientific, USA) which is designed to have very 
high processivity. Then the reaction was run in a thermocycler on a following program: 30 
minutes at 50°C, 5 minutes at 85°C and then cooled down to 4°C. Then, like previously, 
samples could be stored in -20°C 
  Next, I performed RT-qPCR on a LightCycler 480 386-Multiwell Plate (Roche, Switzerland). 
The final volume of each sample on the plate was 10 µl and all the samples were loaded in two 
repeats (duplicates). For microRNA expression measuring we used a TaqMan Universal PCR 
Master Mix (1:2 ratio to final volume) (Roche, Switzerland), specific TaqMan small RNA 
primer mix and template cDNA. For targets qPCR we used LightCycler 480 SYBR Green 
Master mix (1:2 ratio) (Roche, Switzerland), 0.2 µM of both forward and reverse primers, PCR 
grade water and template cDNA (1:2.2 ratio). Samples were then transferred to 
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LightCycler®480 (Roche). Pre-incubation was done at 90°C for 5 minutes. Then, amplification 
program was following: denaturing 95°C for 10 seconds, annealing at 60°C for 10 seconds and 
elongation at 72°C for 10 seconds, repeated for 45 cycles. Then samples were cooled down to 
40°C.  
   
2.10. Western blotting 
 
  For the protein analysis, we performed SDS-PAGE (sodium dodecyl sulfate–polyacrylamide 
gel electrophoresis) and western blotting (WB). Cell cultures were lyzed by adding 100 µl of 
Laemmli sample buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% 
Bromophenol Blue). Then, the cell layer was scraped off the surface and transferred to 1.5 ml 
Eppendorf tubes and incubated on a Heating Block MB-102 (Bioer, Germany) at 95°C for 10 
minutes. After that, sample could be stored at -20°C or continued with SDS-PAGE.  
  The gel for SDS-PAGE consisted of upper (stacking) gel [5% polyacrylamide (PAA) 
(BioRad), 1x upper gel buffer (1M Tris-HCl with pH 6,8, 20% SDS, H2O), 10% ammonium 
persulphate (APS), H2O and 5 µl Tetramethylethylenediamine (TEMED) (BioRad)] and lower 
(resolving) gel [10% PAA, 1x lower gel buffer (3 M Tris-HCl with pH 8,8, 20% SDS, H20), 
10% APS, H2O and 7 µl of TEMED]. Samples were run on 100 V for 1-2 hours and after that 
the gel was carefully transferred on top of the nitrocellulose membrane to transfer proteins from 
the gel to the membrane. This was done in a WB transfer buffer bath (25 mM Tris-HCl, pH 8,3, 
20% SDS, 20% methanol, H2O). The transferring was run in a BioRad system at 100 V for 
about 1,5 hours. When the transferring was complete, the membrane was rinsed 2x in 1xTBS 
(Tris-buffered saline). Then, incubated 2x for 5 minutes in 1xTBS-T (0.1% Tween 20). Next, 
the membranes were blocked by incubating them in 1x TBS-T with 5% skimmed milk for 1 
hour at 4°C on a rotating platform. After that membranes were again washed 4x in 1xTBS-T 
and then treated with primary antibodies by adding 3 ml of primary antibody solution onto the 
membrane. All the antibodies were diluted in 1x TBS-T with 5% skimmed milk (1:1000 anti-
ITSN1/2 and 1:4000 anti-GAPDH antibodies). Primary antibodies against ITNS1 and ITSN2 
were produced in rabbits in the Department of Cell Signalling, Institute of Molecular Biology 
and Genetics, National Academy of Sciences of Ukraine (Kyiv, Ukraine). For the control, we 
used commercial anti-GAPDH antibodies made in mouse (Millipore Corp, Merck, USA). 
Membranes were then incubated at 4°C overnight. Next day, antibody solution was removed 
and they were washed 4x in a 1xTBS-T solution. After that, membranes were treated with the 
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secondary antibodies in a ratio 1:3000 in 5% milk 1xTBS-T solution [anti-mouse for GAPDH 
(Dako) and anti-rabbit for ITSN1/2 (General Electrics Healthcare)]. Membranes were incubated 
for 1 hour at 4°C and then washed again 4x in a 1xTBS-T solution.  
  Before the imaging, membranes were treated with reagents 1 and 2 from PierceTM ECL 
Western Blotting Substrate kit (Thermo Scientific, USA) in a 1:1 ratio. Then, the images were 
taken using a Fujifilm LAS-3000 Imager to analyse and visualize protein bands. 
 
2.11 Statistical analysis 
 
  The preliminary analysis was done in Microsoft Office Excel 2018 spreadsheet software. Raw 
data was exported to Excel, normalized to reference gene or protein and ratios were taken in 
relation to the mean values of control group. The primary statistical analysis was done in 
GraphPad Prism 6 statistics software. The main purpose of the analysis was to compare the 
groups treated with different miRs to the control group that did not contain any specific miR 
sequence and identify the differences of the expression of ITSN1 and ITSN2 and their isoforms 
compared to the control group. The aim of the analysis was to observe and identify which miR 
treated group has a statistically significant change on the expression of ITSNs compared to the 
control group whether by up- or downregulating the expression of the gene. The only variable 
between different groups was the expression of different miRs. NC/control group contained the 
plasmid construct that was used to express various miRs but lacked the specific miR sequence 
in it. 
  Statistical significance was calculated by nonparametric one-way ANOVA statistical test 
followed by Dunnett’s multiple comparison test on the obtained data because in every 
experimental observation I had more than two groups (different microRNA treated groups) to 
compare to the control group. The results with a p-value ≤ 0.05 were considered statistically 
significant. The data in text and figures are represented as means ± standard deviation (SD) to 
show the variation in my data. 
  Western blot images were first analysed in image processing program ImageJ 1.8.0 version. 
The intensity of the bands were quantified to numerical values in the program and then exported 
to Excel for further preliminary analysis.  
   
  
30 
 
3. Results 
 
3.1 Selection of microRNAs 
 
  To find out which microRNAs are the best candidates regulating and binding to 3’UTRs of 
intersectins we performed a bioinformatic analysis by using different microRNA and their 
target databases online. I used a wide selection of databases that can predict, based on the 
sequence, microRNAs that are the best candidates to interact to the given target gene. 
MircroRNA target prediction databases that were used are TargetScan, microRNA, PicTar 
(2005v), PicTar (2006v), miRWalk, miRBD, PITA and RNA22. We queried these databases to 
see which microRNAs are most complementary to 3’UTRs of ITSN1-S, ITSN1-L and ITSN2-
L. From the search and the subsequent analysis, we chose the best candidates (Table 3.1) that 
were also supported by additional literature on that field (Sharma & Lu, 2018). 
 
Table 3.1. Predicted conservative microRNA target sites in 3’UTRs of ITSN isoforms. For ITSN2-S, online 
servers did not predict any conservative microRNAs. Abbreviations for serves shown on the table are the 
following: TS- TargetScan, MR – microRNA, PT5 – PicTar2005, PT6 – PicTar2006, MW – miRWalk, MD – 
miRBD, PT – PITA, RN- RNA22. 
 
  From these selected microRNAs (Table 3.1) we further selected miR-181a, miR-30a, miR-
128-3p, miR-124a, miR-17-19, miR-218 and miR-19ab-3p. These are microRNAs that have 
been already associated with neurodegenerative diseases and tumours and/or were 
complementary to the given 3’ UTRs (Juźwik et al., 2019; Sharma & Lu, 2018). Note that we 
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did not find any conserved binding sites (microRNAs) for the 3’UTR of ITSN2-S mRNAs 
(Table 3.1).  
 
3.2. Regulation of 3’UTRs of intersectins by microRNAs in 
HEK293T cells 
 
  To measure which of our chosen microRNAs have a significant effect on the ITSNs expression 
we cloned 3’UTRs of ITSN1-S, ITSN2-L and ITSN1-L-A/-B/-C to the commercial 
psiCHECK™-2 vector. MicroRNAs that were shown by bioinformatic analysis to have the 
strongest complementary to the 3’UTRs were cloned to the pcDNATM6.2-GW/EmGFP-miR 
vector backbone. Plasmids were transfected to the HEK293T cells and cultured for 48 hours 
and then analysed by Dual-Luciferase assay, as described in the Materials and Methods section. 
All Dual-Luciferase assays were repeated in four independent biological replicas (N = 4). All 
the miR treated groups were primarily compared to negative controls (NC) that contained a 
backbone of pcDNATM6.2-GW/EmGFP-miR vector with scrambled miR sequence, predicted 
not to target any mammalian gene(s); but also, additionally, against cultures that contained only 
target vector psiCHECK™-2. I used the expression of EmGFP protein, expressed from the 
pcDNATM6.2-GW/EmGFP-miR vector, to track if the cells had been transfected with the 
expression vector in the culture. 
 
 
Figure 3.2. Image of HEK293T cells transfected by pcDNATM6.2-GW/EmGFP-miR expression vector. The 
expression vector contains a gene for EmGFP protein. Expression of this protein allows to track if the cells have 
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been transfected by the vector. It is also an indirect way to confirm if the cells are also expressing our chosen 
microRNAs. As one can see from the image not all the cells will get transfected. Scale bar: 125 µm. 
 
  3’UTR of ITSN1-S was tested with miR-218, miR-30. Results from ITSN1-S (Figure 3.1.) 
showed that in the presence of miR-218 the ITSN1-S transcript is slightly up-regulated but the 
observed data was not statistically significant (p > 0.05). The expression of miR-30 did not have 
a considerable effect on the levels of ITSN1-S 3’UTR transcript. ITSN2-L was tested with miR-
124 and miR-128. Results obtained with 3’UTR of ITSN2-L did not demonstrate significant 
up- of downregulation of the transcript. Though we did observe a trend for a slight upregulation 
by both miR-124 and miR-128, this was not statistically significant in one-way ANOVA test.  
 
 
Figure 3.3. Dual-Luciferase assay results obtained in HEK293T cells. A. Regulation of 3’UTR transcript of 
ITSN1-S was tested by miR-218 and miR-30. B. ITSN2-L regulation was tested by miR-124 and miR-128. The 
bars of each group show mean values ± SD of four (N=4) independent experiments in same conditions. NC group 
contained only pcDNATM6.2-GW/EmGFP-miR vector backbone but no specific miRNA sequence. Bars indicated 
as “3’UTR only” were transfected only with psiCHECK™-2 vector. The results did not show statistically 
significant changes (one-way ANOVA, p > 0.05) of ITSN1-S and ITSN2-L transcript levels in miR treated groups. 
 
  The 3’UTR of ITSN1-L regulation in HEK293T cell culture in luciferase assay were tested in 
three different segments (ITSN1L-A, ITSN1L-B and ITSN1L-C) as described in Materials and 
Methods. The expression levels of 3’UTR fragment of ITSN1L-A was tested with miR-181 and 
miR-30. Though we observed a slight upregulation of the transcript in the presence of miR-181 
and a slight downregulation with the expression of miR-30, in both cases it was not statistically 
significant (p > 0.05). ITSN1L-B fragment was tested with miR-19, miR-17-19, miR-124, miR-
218 and miR-181. There, I observed that in the presence of miR-124 the levels of target 
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(ITSN1L-B fragments) 3’UTRs were lower than the control ones though not significant (p > 
0.05). Expression of miR-181 and miR-19 both considerably increased the expression of 
ITSN1L-B fragment but were not significant (p > 0.05) either. The third fragment of 3’UTR 
(ITSN1L-C) was tested with miR-124, miR-128 and miR-218 but the results did not reveal any 
statistically significant changes in the expression of 3’UTR of ITSN1L-C fragment. 
  Also, before the start of this master thesis project, Dmytro Gerasymchuk had shown a 
statistically significant downregulation of 3’UTR of ITSN1-S by miR-181a-5p (miR-181 from 
here on) in Dual-Luciferase assays (unpublished data). 
 
 
Figure 3.4. Dual-Luciferase assay results for three segments (A, B, C) of ITSN1-L in HEK293T cells. A. ITSN1L-
A was tested with miR-181 and miR-30. ITSN1L-A transcript levels were not significantly decreased (p > 0.05) 
by given miRs. B. ITSN1L-B segment was treated with miR-218, miR-181, miR-124, miR-19 and miR-17-19. 
Treatment with given miRs did not show significantly decrease (p > 0.05) ITSN1L-B transcript levels. C. ITSN1L-
C segment was also treated with miR-218, miR-128 and miR-124. ITSN1L-C transcript levels were also not 
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significantly decreased (p > 0.05) in any miR treated group. The bars show mean values ± SD of N=4 independent 
experiments. 
 
  In these results, 3’UTRs of interectins were expressed from transfected psiCHECK™-2 
vector. Meaning, the expression construct and the gene of interest itself is actually an artificial. 
Next, we wanted to confirm these results and observe intersectin mRNA levels in endogenously 
expressed transcripts in HEK293T cells. So, for that, we transfected HEK293T cells only with 
miR constructs and analysed them by performing RT-qPCR. 
 
3.3. Endogenous regulation of ITSNs in HEK293T cells by 
microRNAs 
 
  To study the regulation of endogenously expressed ITSNs by microRNAs we measured 
expression of both ITSN1 and ITSN2 genes indistinctively from long (L) and short (S) isoforms 
but also mRNA levels of ITSN1-L isoform only. ITSN1 mRNA levels were measured in miR-
19, miR-181, miR-124 and miR-30 treated cell cultures. RT-qPCR results showed that miR-
124 expression significantly downregulates (one-way ANOVA, p ≤ 0.05) ITSN1 mRNA levels 
in HEK293T cells. ITSN1 mRNA levels were decreased by approximately 80%. Expression of 
miR-30, miR-181 and miR-19 did not show significant changes in ITSN1 mRNA levels though 
there was slight up-regulation with miR-181 compared to control and downregulation with 
miR-30 and miR-19 (Figure 3.4. A.). Interestingly, expression of miR-19 significantly 
downregulated (p ≤ 0.005) ITSN1-L isoform mRNA by approximately 50% (Figure 3.4. B.). 
Transduction with miR-181 increased ITSN1-L mRNA expression level noticeably but it was 
not statistically significant and had a wide variation in data points. Regulation of ITSN2 mRNA 
levels were tested with miR-181, miR-124, miR-30 and miR-19. When analysing the fold 
changes of expression levels in ITSN2 we found no significant changes. Though there was a 
noticeable increase in the presence of miR-19, it was again not significant (p > 0.05) and the 
replicas had a big variation in data points (Figure 3.4 C.). Suprisinlgy, expression of all other 
miRs – miR-181, miR-124 and miR-30 – seemed to increase ITSN2 mRNA levels 
approximately 2-3 folds. 
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  Figure 3.5. Regulation of endogenously expressed ITSNs by miRs. A. mRNA levels of ITSN1 (total of isoforms 
ITSN1-S and ITSN1-L) treated with miR-181, miR-30, miR-124 and miR-19 respectively. ITSN1 mRNA level is 
significantly decreased (p ≤ 0.05) by approximately 80% in miR-124 treated HEK293T cells compared to NC as 
shown by RT-qPCR. Asterisk sign on the figure indicates the statistical significance (p ≤ 0.05) between two groups. 
B. mRNA levels of only ITSN1-L isoform tested with miR-181, miR-30, miR-124 and miR-19. Interestingly, 
ITSN1-L mRNA level is significantly decreased (p ≤ 0.005) by approximately 50% in miR-19 treated group of 
HEK293T cells compared to NC. Two asterisk signs on the figure indicates the statistical significance (p ≤ 0.005) 
between two groups. C. mRNA levels of ITSN2 (total of isoforms ITSN2-S and ITSN2-L) tested with miR-181, 
miR-30, miR-124 and miR-19. Expression of given miRs did not significantly change (p > 0.005) the level of 
ITSN2 mRNA. The bars show mean values ± SD of N=3 independent experiments. 
 
  Next, we aimed to study the changes in protein levels of endogenously expressed ITSNs. For 
that I treated HEK293T cells with miR-181 and miR-30 and after 48 hours of transfection 
performed a western blot analysis. Western blot bands were quantified by ImageJ software and 
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the analyses of the results revealed no significant changes (p > 0.05) in the protein level when 
comparing groups that were transfected with microRNAs to untransfected group (Figure 3.5.) 
and also when comparing only microRNA bands with one another.  
  The western blotting was performed only for ITSN1 because ITSN2 antibodies were not 
available at that time. 
 
 
  Figure 3.6. Western blot of ITSN1 protein from the HEK293T culture transfected with different microRNAs. 
GAPDH, a protein of a widely expressed housekeeping gene, was used as a control. 3 different biological replicates 
(N=3) were analysed on the western blot image, where each transfection (TF1/2/3) represents a single biological 
repeat. Quantification of the bands did not reveal a statistically significant changes (p > 0.05) on the expression of 
ITSN1 in miR treated groups. The bars show mean values ± SD of N=3 independent experiments of each group 
Abbrevations: OE – overexpression, UT – untransfected, 30 – miR-30, 181 – miR-181, NC – miR-NC, M – marker. 
 
3.4. ITSNs regulation in human neuronal stem cells 
 
   Second aim of this master thesis was to culture human NSCs, differentiate them into viable 
human neuronal cells that are possible to use in experiments and then study the expression of 
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ITSN1 and ITSN2 genes by expression of microRNAs via lentivector-based transduction. We 
transduced human neuronal stem cells HEL47.2 with pCDH-hSyn-MCS-T2A-EGFP-EmGFP-
miR plasmids bearing miR-181, miR-30, miR-124 or miR-NC microRNA sequences after 
NSCs differentiated into human neuronal stem cells. After 7 days of incubation, starting from  
transduction, expression of this plasmid was confirmed by tracking the expression of EmGFP 
protein in neuronal cells under fluorescence microscopy (EVOSTM FLoid, Thermo Fisher 
Scientific, USA) (Figure 3.6) and then analysed by RT-qPCR.  
 
Figure 3.7. NSCs developed into human neuronal cells after 7 days from transduction with EmGFP-miR (green 
fluorescent protein) containing lentivector. Cell cultures were transduced with miR-181 (A.), miR-124 (B.), miR-
30 (C.), and miR-NC (D.). N=3 independent biological replicas were cultured with each miR in neuronal cell 
cultures. The contrast and the brightness of the images was adjusted in ImageJ 1.8v software. Scale bar: 100 µm. 
 
  After imaging, we performed RT-qPCR to measure ITSN1 and ITSN2 gene expression which 
was done in three independent biological replicas (N = 3). In the figure 3.7. A. we can see that 
the expression of miR-181 and miR-30 slightly increased the level of ITSN1 mRNA levels 
compared to the control group but it was not significant (one-way ANOVA, p > 0.05). 
A. B. 
C. D. 
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Expression of miR-124 did not change the mRNA level of ITSN1 significantly either. Looking 
at the graph B in figure 3.7 we can also see that the expression of miR-30 noticeably increased 
mRNA level of ITSN2 by approximately 2-fold compared to NC group, though the difference 
between two groups were not statistically significant (p > 0.05). Overall, RT-qPCR results 
obtained in neuronal cells did not demonstrate that expression of given miRs significantly 
change the ITSN1 and 2 mRNA levels compared to control group.  
 
 
Figure 3.8. Expression of ITSN1 (A) and ITSN2 (B) mRNA levels, respectively, in neuronal cells. Cells were 
analysed with three different miRs – miR-181, miR-30 and miR-124. Three biological replicates (N=3) were used 
to analyse ITSN1 and ITSN2 mRNA levels in neurons. The bars show mean values ± SD of N=3 independent 
experiments of each group. Results from RT-qPCR experiments did not show significant changes (p > 0.05) in 
miR treated groups. 
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4. Discussion 
 
  The first objective of this study was to construct vectors bearing the sequences of 3’UTRs of 
ITSNs, microRNAs and lentivirus particles that are able to transduce neuronal stem cells and 
to express microRNA bearing vectors successfully in neurons. The main goal of this thesis was 
to analyse regulation of intersectins by different microRNAs in HEK293T cell line and human 
neuronal cell line HEL47.2. It was done by performing dual-luciferase assays with the 
constructed ITSNs 3’UTR sequences containing plasmids in HEK293T cell lines. Next, 
performing RT-qPCR in HEK293T cell cultures that were expressing our chosen microRNAs 
and finally culturing human derived neuronal stem cells HEL47.2, expressing microRNAs in 
those cell cultures and measuring mRNA levels from ITSN1 and ITSN2 genes.  
  Data obtained from the Dual-Luciferase assays, where I expressed a variety of micoRNAs, 
unfortunately did not show the expected up- or downregulation of targets level as it was 
predicted by online databases. None of the miRs that were expressed in those assays did not 
significantly change the expression level of any 3’UTR transcript (ITSN1S, ITSN2L, ITSN1L-
A/B/C). These results also illustrate the fact that such predictions made in online databases 
should always be taken by caution and confirmed experimentally. Nevertheless, these results 
had to be confirmed in additional experiment where targets are endogenously expressed. 
Because, as it was mentioned earlier, dual-luciferase assay itself is an artificial system but 
nonetheless it is a good way to test miR and target interaction. 
  Results from dual-luciferase assay were confirmed by RT-qPCR. The selection of miRs were 
further narrowed to four - miR-181, miR-124, miR-30 and miR-19 – since these microRNAs 
were the most promising candidates. These results demonstrated that the expression of miR-
124 significantly (p ≤ 0.05) downregulate ITSN1 mRNA level by approximately 80%. ITSN1 
down expression was a total of both ITSN1-S and ITSN1-L isoforms. This data suggests that 
miR-124 interacts with ITSN1 transcript and causing the downregulation of this gene. I also 
wanted to study the expression of only ITSN1-L isoform since it is the most abundant isoform 
of ITSN proteins in neurons. Interestingly, expression of only this isoform, was significantly 
downregulated (p ≤ 0.005) by miR-19. ITSN1-L mRNA level was decreased by approximately 
50%. This, seemingly contradicting data, could suggest that miR-124 is primarily interacting 
with ITSN1-S isoform and that ITSN1-S is more abundant isoform from the total expression of 
ITSN1 gene. For ITSN2, I did not observe significant up- or downregulation by given 
microRNAs. Even so it is interesting to note that contrary to ITSN1 and ITSN1-L, expression 
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of given miRs seem to increase ITSN2 mRNA levels. Nonetheless, all those experiments should 
be repeated in more biological replicas so that we can get statistically more accurate overview 
of the data and, of course, to verify previous results.  
  Also, we performed a Western blotting to analyse the protein levels after the treatment with 
microRNAs but the results did not reveal significant changes in protein level between 
microRNA treated samples and untreated (NC) samples. The protein analysis was only 
performed for ITSN1 because of the lack of antibodies for ITSN2 protein and cell cultures were 
treated with miR-181 and miR-30. Western blotting results showed that even after the treatment 
with the given microRNAs the ITSN1 protein levels remain approximately at the same level 
compared to the untreated group. One reason for this observation could be because the cells 
were lyzed already 48 hours after transfection with microRNAs. It is known that ITSNs are 
quite stable proteins (Tong et al., 2000). Which means it could take more time to observe the 
differences in protein levels after the cells are transfected with microRNAs. Future studies of 
the ITSN regulation should consider culturing the cells for longer time after transfecting them 
with microRNAs, for example, by creating stably transfected cell lines. 
  Finally, we analysed endogenous regulation of ITSNs in human neuronal cells. These neuronal 
cells were derived from the iPSCs that were obtained from healthy male dermal fibroblasts in 
Biomedicum Stem Cell Center, University of Helsinki (Trokovic et al. 2015). NSCs were let to 
differentiate into neurons for a week and then transduced with lentivirus particles containing 
miR-181, miR-124 or miR-30 bearing vectors. Images of neuronal cell cultures from 
fluorescence microscopy did show that neurons were expressing EmGFP protein. That also 
confirms that cells contained lentivectors and were expressing miRs. Unfortunately, what I 
found, was that the expression of given miRs did not significantly decrease or increase the 
expression of either ITSN1 or ITSN2 mRNA levels in human neurons compared to the control 
group. Part of the reason why there have not been statistical significance in many of the results 
may be because of the large sample-to-sample variation. One way to improve it could be by 
increasing the number of biological replicas. 
  As it was mentioned already, dual-luciferase assay results had certain limitations in its design 
and needed to be complemented with RT-qPCR. But RT-qPCR test is not a perfect experiment 
either. It highly depends on the purity of RNA samples and slightest contamination in RNA 
could lead to misleading or faulty results. Also, this approach only shows changes in mRNA 
level. That is why western blot results are needed because it shows expression changes in 
protein level. In this thesis, I only tested ITSN1 protein levels but future studies should certainly 
demonstrate how ITSN2 protein level is changed by the expression of microRNAs.  
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  We also saw that for the microRNAs that did had a significant effect on ITSNs expression did 
not block its expression entirely but rather decreased it, which is also consistent with the 
literature on microRNAs and their mechanism of action (O’Brien et al., 2018). Based on our 
results, the author suggests that the most significant microRNAs regulate gene expression by 
promoting mRNA decay because RT-qPCR results showed a significant fold changes in mRNA 
levels of ITSN1. 
  Future studies should investigate the effect of multiple microRNAs at the same time on the 
cell cultures. In the given study, we investigated the effect of microRNAs independently and 
compared each microRNA to each other but subsequent studies should certainly look into how 
multiple microRNAs can influence gene expression cooperatively.  
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